Patent ID: 9211241
Filing Date: 2015-12-15
Classification: A61K,A61Q

Abstract:
1. An oral composition, comprising the following components (A) and (B): (A) an N-acyl glutamic acid or a salt thereof in an amount of 0.005 mass % or more and 0.3 mass % or less; and (B) pyrophosphoric acid or a salt thereof in an amount of 0.005 mass % or more and 0.5 mass % or less, wherein a mass ratio ((B)/(A)) of the component (B) to the component (A) is 0.05 or more and 40 or less, and a total content of the component (A) and the component (B) is 0.01 mass % or more and 0.6 mass % or less, wherein the acyl group of component (A) is selected from one or more of the group consisting of a lauroyl group, a myristoyl group and a cocoyl group.